Long-Term Adaptation As habits stabilize and dosing is optimized, weight loss may become more consistent over time
EMPA-REG OUTCOME (N=7,020) showed empagliflozin reduced cardiovascular death by 38% (HR 0.62, 95% CI 0.49, 0.77) and hospitalization for heart failure by 35% (HR 0.65, 95% CI 0.50, 0.85) [10]
Addressing them prevents poor decision-making based on inaccurate information
Whether you're getting the injection or the oral tablet, whether it's Wegovy or Zepbound or Foundayo, the cost is $50
These are unstable molecules that can cause cellular wear and tear over time
Tirzepatide (Mounjaro, ZepBound): This dual-action medication mimics both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP, another naturally occurring hormone), resulting in even greater weight loss for many people